Company Overview of RiboCor, Inc.
RiboCor, Inc. develops and markets pharmaceuticals to treat prevalent chronic diseases in the United States and internationally. The company focuses in the areas of cardiovascular medicine and the treatment of fibromyalgia. It also develops products for biologic (blood banking industry) applications, such as functional enhancement of red blood cells and platelets. In addition, the company distributes Corvalen products for professional use to health care professionals, clinics, pharmacies, and their patients. RiboCor, Inc. was formerly known as Bioenergy, Inc. and changed its name to RiboCor, Inc. in April 2012. The company was founded in 1986 and is based in Minneapolis, Minnesota.
7077 Northland Circle North
Minneapolis, MN 55428
Founded in 1986
Key Executives for RiboCor, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact RiboCor, Inc., please visit www.ribocor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.